Life insurance, reimagined

Longevity Science

We’re changing how life insurance companies underwrite and sell their products with a proven technology platform driven by molecular biotechnology.

The power
of epigenetics
AI

The epigenetic clock measures biological aging in a unique way. Studies have shown that individuals who have faster epigenetic clocks are aging faster biologically and, subsequently, are at greater risk for all-cause mortality. [1]

Epigenetic measurements also provide insights into how and why we age, making them an important new tool in longevity research.

[1] Lu et al. Aging (Albany NY). 2019 Jan 31; 11(2): 303–327.

What exactly is epigenetics?

DNA is your genetic code.

Inherited from parents
Fixed at birth
Determines ancestry, ethnicity, gender, hair and eye color, and predisposition to health risks

Epigenetics is the expression of that code.

Changing, modifiable, adapting, and reacting
Associated with age-related decline, and disease states
Impacted by tobacco, alcohol, drugs of abuse, diet, exercise, stress, and environmental factors

Next-gen science and technology

Epigenetic technology has been proven to provide health, lifestyle, and longevity insights that have never before been accessible to humans—from just a single saliva sample.

As pioneers in the development and integration of epigenetic biomarkers into state-of-the-art underwriting protocols and consumer engagement tools, FOXO is using next-generation technology to transform human health and longevity.

Epigenetic clock technology

Epigenetic clocks developed in the Horvath Lab at UCLA are exclusively licensed by FOXO for use in actuarial predictive modeling and underwriting.

Mortality predictor EEAA

The Mortality Predictor EEAA estimates biological aging based on methylation patterns in humans. It was developed by assessing blood to predict all-cause mortality in 13 different cohorts for a total sample size of 13,089 individuals in different racial and ethnic groups.

PhenoAge

PhenoAge is a new epigenetic biomarker of aging that measures healthspan in regard to predictions for a variety of aging outcomes, including cancers, healthspan, physical functioning, and Alzheimer’s disease.

GrimAge

GrimAge is a measure of epigenetic age, acceleration of aging, that strongly measures all-cause mortality. Using large scale validation data from thousands of individuals, GrimAge demonstrates striking accuracy among existing epigenetic clocks.

Proprietary epigenetic biomarkers

Automated machine learning examines thousands of models to find patterns of DNA methylation (i.e., epigenetic biomarkers) that measure health and wellness for underwriting and consumer engagement.

Case study: smoking impact on twins

Identical twins share the same genes, but they can experience vastly different health outcomes based on lifestyle factors like smoking.

Epigenetic biomarkers can identify smokers at the same level of accuracy as the industry standard cotinine tests. FOXO’s smoking biomarker also identifies regular smokers who stop smoking for several days prior to testing, protecting carriers against insurance fraud.

A bold vision.

Revolutionizing life insurance

Using saliva-based epigenetic biomarkers, we’re eliminating the need for invasive blood and urine collection. No more long waits or discomfort. Plus, policyholders will receive a personalized longevity report with key wellness insights. It’s a novel value proposition that marks a paradigm shift in how humans approach lifespan.